UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051254
Receipt number R000058449
Scientific Title Estimation of hemodynamic status (blood pressure, pulse rate) and prediction of hemodynamic changes from pulse wave using wearable terminal in patients requiring systemic management in HCU.
Date of disclosure of the study information 2023/07/01
Last modified on 2023/06/03 16:31:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Monitoring hemodynamic status (blood pressure, pulse) and predicting dynamic changes using wearable devices in patients requiring systemic management while in the HCU

Acronym

Hemodynamic monitoring and prediction study of dynamic changes using wearable devices in intensive care

Scientific Title

Estimation of hemodynamic status (blood pressure, pulse rate) and prediction of hemodynamic changes from pulse wave using wearable terminal in patients requiring systemic management in HCU.

Scientific Title:Acronym

Hemodynamic (blood pressure, pulse rate) estimation from pulse wave and prediction of hemodynamic changes in intensive care

Region

Japan


Condition

Condition

Heart failure (circulatory failure), hypotension, shock

Classification by specialty

Medicine in general Cardiology Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To understand hemodynamics (blood pressure and pulse rate) and predict dynamic changes in critically ill patients with circulatory failure based on estimated pulse rate and blood pressure from pulse wave using a wearable device.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Assessing the accuracy of immediate measurement of vital signs from arterial catheters versus estimated vital signs
Differences between future predicted dynamics and actual dynamic fluctuations

Key secondary outcomes

Correlation with oxygen saturation, body temperature, and other related measures of cardiovascular indices


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Persons who meet the criteria for admission to the intensive care unit and who have given consent to the study description.
Patients with an indwelling arterial catheter.

Key exclusion criteria

Patients who did not consent

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takehito
Middle name
Last name KOBAYASHI

Organization

Saitama Medical University

Division name

General international medicine

Zip code

350

Address

38 Monohongo, Monoyama-Cho, Iruma-gun, Saitama, JPN

TEL

0492761667

Email

kobatake@saitama-med.ac.jp


Public contact

Name of contact person

1st name Takehito
Middle name
Last name KOBAYASHI

Organization

Saitama Medical University

Division name

General Internal Medicine

Zip code

350-0495

Address

38 Monohongo, Monoyama-Cho, Iruma-gun, Saitama, JPN

TEL

0492761667

Homepage URL


Email

kobatake@saitama-med.ac.jp


Sponsor or person

Institute

saitama medical university

Institute

Department

Personal name

Takehito KOBAYASHI


Funding Source

Organization

Grants-in-Aid for Scientific Research(KAKENHI)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

JPN


Other related organizations

Co-sponsor


Name of secondary funder(s)

Saitama Medical University General Research Fund


IRB Contact (For public release)

Organization

Saitama Medical University Hospital Institutional Review Board

Address

38, Muro Hongo, Muroyama-cho, Iruma-gun, Saitama, Japan

Tel

0492761354

Email

hirb@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学病院


Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2023 Year 07 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Improvements will be made to previous devices.
Preparing to apply for a patent on the research results.


Management information

Registered date

2023 Year 06 Month 03 Day

Last modified on

2023 Year 06 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058449


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name